Doxorubicin‐induced cardiomyocyte toxicity – protective effects of endothelial cells in a tri‐culture model system

Doxorubicin‐induced cardiomyopathy is a clinically prevalent pathology, occurring as a sequelae following chemotherapy for cancer patients. In particular, the “first dose” effect has been particularly challenging, given the heterogeneous and multifactorial nature of this pathophysiology. Here, we describe the development of a physiologically relevant in vitro model for cardiotoxicity testing, using human cells. Primary cardiomyocytes, endothelial, and smooth muscle cells were tri‐cultured in 2D, or within nano‐fibrous scaffolds in a 3D environment, under dynamic nutrient flow, using the Quasi Vivo® system. State‐of‐the‐art sensor chips were used to detect troponin I levels, 2 h after acute exposure to doxorubicin. We demonstrate a significant improvement in cardiomyocyte viability when grown in a 3D tri‐culture environment over a 5‐day period and a 10‐fold reduction in doxorubicin‐induced toxicity. Our tri‐culture model can be used as a valuable tool for physiologically relevant assessment of drug‐induced cardiotoxicity in vitro. Here, we describe the development of a physiologically relevant in vitro model for cardiotoxicity testing, using a Quasi Vivo chamber (A). Primary cardiomyocytes, smooth muscle cells, and endothelial cells (B) were tri‐cultured in 2D, or within a nano‐fibrous scaffold, under dynamic nutrient flow conditions. We demonstrate a significant improvement in cardiomyocyte viability and reduced doxorubicin‐induced toxicity when grown in a 3D tri‐culture environment.